Is OIC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of OIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: OIC (CHF10.38) is trading above our estimate of fair value (CHF9.86)
Significantly Below Fair Value: OIC is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for OIC?
Key metric: As OIC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for OIC. This is calculated by dividing OIC's market cap by their current
revenue.
What is OIC's PS Ratio?
PS Ratio
1.3x
Sales
US$1.95b
Market Cap
US$2.48b
OIC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: OIC is expensive based on its Price-To-Sales Ratio (1.3x) compared to the European Chemicals industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is OIC's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
OIC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
1.3x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate OIC's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst OIC forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
n/a
CHF 17.08
0%
46.1%
CHF 32.83
CHF 11.84
n/a
9
Nov ’25
CHF 10.38
CHF 22.88
+120.3%
40.9%
CHF 33.31
CHF 11.60
n/a
9
Oct ’25
n/a
CHF 30.01
0%
6.0%
CHF 32.36
CHF 27.45
n/a
9
Sep ’25
n/a
CHF 29.67
0%
6.8%
CHF 32.44
CHF 24.84
n/a
12
Aug ’25
n/a
CHF 29.22
0%
11.5%
CHF 36.31
CHF 22.93
n/a
12
Jul ’25
n/a
CHF 29.16
0%
14.0%
CHF 37.07
CHF 21.41
n/a
13
Jun ’25
n/a
CHF 29.70
0%
13.8%
CHF 37.46
CHF 21.82
n/a
13
May ’25
n/a
CHF 29.53
0%
15.7%
CHF 37.54
CHF 21.74
n/a
12
Apr ’25
n/a
CHF 29.03
0%
14.9%
CHF 36.44
CHF 22.40
n/a
12
Mar ’25
n/a
CHF 29.00
0%
14.9%
CHF 36.29
CHF 22.31
n/a
12
Feb ’25
n/a
CHF 26.63
0%
17.4%
CHF 35.58
CHF 18.84
n/a
12
Jan ’25
n/a
CHF 25.00
0%
16.4%
CHF 35.50
CHF 18.80
n/a
12
Dec ’24
n/a
CHF 25.56
0%
16.5%
CHF 36.11
CHF 19.10
n/a
12
Nov ’24
n/a
CHF 29.10
0%
17.3%
CHF 40.37
CHF 22.95
CHF 10.38
12
Oct ’24
n/a
CHF 30.12
0%
15.9%
CHF 40.70
CHF 24.02
n/a
12
Sep ’24
n/a
CHF 29.70
0%
21.5%
CHF 45.25
CHF 23.19
n/a
13
Aug ’24
CHF 25.10
CHF 28.45
+13.4%
21.0%
CHF 44.55
CHF 21.97
n/a
12
Jul ’24
n/a
CHF 31.21
0%
21.0%
CHF 45.16
CHF 24.56
n/a
12
Jun ’24
n/a
CHF 32.32
0%
19.9%
CHF 45.47
CHF 24.73
n/a
12
May ’24
n/a
CHF 34.28
0%
17.1%
CHF 44.78
CHF 24.21
n/a
11
Apr ’24
n/a
CHF 35.73
0%
13.9%
CHF 45.83
CHF 29.21
n/a
11
Mar ’24
n/a
CHF 37.06
0%
11.8%
CHF 43.79
CHF 30.09
n/a
10
Feb ’24
n/a
CHF 39.18
0%
8.8%
CHF 45.74
CHF 32.69
n/a
10
Jan ’24
n/a
CHF 41.70
0%
9.3%
CHF 47.49
CHF 32.82
n/a
10
Dec ’23
n/a
CHF 43.19
0%
9.0%
CHF 49.05
CHF 33.90
n/a
10
Nov ’23
n/a
CHF 44.28
0%
9.5%
CHF 51.42
CHF 35.54
n/a
10
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.